Caio Haddad Franco

Dr. Caio Haddad Franco

Institut Pasteur de São Paulo, São Paulo, Brazil
+1
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2018 in Polar Biology
Verified
Journal Article
Closed access
PDF file
TSTiago Silva
Tiago Silva
Alysson Wagner Fernandes DuarteAlysson Wagner Fernandes Duarte
Alysson Wagner Fernandes Duarte
MPMichel R. Z. Passarini
Michel R. Z. Passarini
ARAna Lucia Tasca Gois Ruiz
Ana Lucia Tasca Gois Ruiz
Caio Haddad FrancoCaio Haddad Franco
Caio Haddad Franco
VOValéria Maia Oliveira
Valéria Maia Oliveira

Verified
Journal Article
Open access
PDF file
Caio Haddad FrancoCaio Haddad Franco
Caio Haddad Franco
Laura Maria AlcântaraLaura Maria Alcântara
Laura Maria Alcântara
ECEric Chatelain
Eric Chatelain
LFLucio H. G. Freitas-Junior
Lucio H. G. Freitas-Junior
CMCarolina Borsoi Moraes
Carolina Borsoi Moraes
Cell-based screening has become the major compound interrogation strategy in Chagas disease drug discovery. Several different cell lines have been deployed as host cells in screening assays. However, host cell characteristics and host-parasite interactions may play an important role when assessing anti-T. cruzi compound activity, ultimately impacting on hit discovery. To verify this hypothesis, four distinct mammalian cell lines (U2OS, THP-1, Vero and L6) were used as T. cruzi host cells in High Content Screening assays. Rates of infection varied greatly between different host cells. Susceptibility to benznidazole also varied, depending on the host cell and parasite strain. A library of 1,280 compounds was screened against the four different cell lines infected with T. cruzi, resulting in the selection of a total of 82 distinct compounds as hits. From these, only two hits were common to all four cell lines assays (2.4%) and 51 were exclusively selected from a single assay (62.2%). Infected U2OS cells were the most sensitive assay, as 55 compounds in total were identified as hits; infected THP-1 yielded the lowest hit rates, with only 16 hit compounds. Of the selected hits, compound FPL64176 presented selective anti-T. cruzi activity and could serve as a starting point for the discovery of new anti-chagasic drugs.

1 November 2017 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
DSDaniel G. Silva
Daniel G. Silva
JRJean F.R. Ribeiro
Jean F.R. Ribeiro
Daniela De VitaDaniela De Vita
Daniela De Vita
LCLorenzo Cianni
Lorenzo Cianni
Caio Haddad FrancoCaio Haddad Franco
Caio Haddad Franco
CMCarlos A Montanari
Carlos A Montanari

25 March 2019 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
PLPasquale Linciano
Pasquale Linciano
Cecilia PozziCecilia Pozzi
Cecilia Pozzi
LILucia Dello Iacono
Lucia Dello Iacono
FPFlavio di Pisa
Flavio di Pisa
GLGiacomo Landi
Giacomo Landi
MCMaria Paola Costi
Maria Paola Costi

1 February 2018 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
PLPasquale Linciano
Pasquale Linciano
CMCarolina B. Moraes
Carolina B. Moraes
Laura Maria AlcântaraLaura Maria Alcântara
Laura Maria Alcântara
Caio Haddad FrancoCaio Haddad Franco
Caio Haddad Franco
BPBruno Pascoalino
Bruno Pascoalino
MCMaria Paola Costi
Maria Paola Costi

1 October 2016 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
FSFredson T. Silva
Fredson T. Silva
Caio Haddad FrancoCaio Haddad Franco
Caio Haddad Franco
DFDenize C. Favaro
Denize C. Favaro
LFLucio H. Freitas-Junior
Lucio H. Freitas-Junior
CMCarolina B. Moraes
Carolina B. Moraes
EFElizabeth Igne Ferreira
Elizabeth Igne Ferreira